Business4 weeks ago
Slow Rollout of First CRISPR-Based Treatment for Sickle Cell Disease
Mon 23rd Dec, 2024 Deshawn Chow, a 19-year-old diagnosed with sickle cell disease, recently received a groundbreaking treatment known as Casgevy, which is the first approved...
